3577 results for «2381»
3577 results
Cases in TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging TAVI cases, such as: subacute occlusion of right coronary artery after surgical aortic valve replacement, large post-myocardial infarction ventricular septum defect closure, NSTEMI after complex PCI and transfemoral TAVI procedure, and more!
Stroke Prevention Day - Essentials in LAA closure
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about patient selection for LAA closure, the importance of TEE/CT imaging to identify LAA anatomy/morphology, and discover how to detect immediate/late complications and how to manage them, thanks to a selection of various challenging cases.
Stroke Prevention Day - PFO
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn how to build a stroke prevention team, what are the indications and pre-procedural screening of PFO closure, and discover the step-by-step procedure of PFO closure thanks to a selection of cases and studies.
Remaining limitation of TAVI
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the remaining limitation of TAVI, such as conduction abnormalities, coronary access, severe aortic valve calcification, thanks to a selection of various interesting cases.
TAVI basics Co-Medicals - in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session in japanese to learn more about the roles of co-medicals (before and after procedure), the decision-making and strategies prior to TAVI, and the management of comorbidities post TAVI.
My best and worst cases of vascular access
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn thanks to a selection of challenging transcatheter aortic valve implantation cases how to analyse the access sites required, how to manage difficult access and complications, and discover some new approaches.
Aortic Valve Thrombosis
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session on aortic valve thrombosis to learn how to manage the patients with a bioprosthetic valve at high risk of thrombosis and bleeding, and the key role of imaging (echo and CT) in these situations.
Shared decision making in low-risk patients with aortic stenosis
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover how the concept of low-risk applies in Asian clinical practice, what is the impact of the TAVI low-risk trials on the management of individual patients, and learn more about the future role of the Heart Team.
Strategies to handle complications during interventions for structural heart disease: my worst nightmare - Part 1
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn all about how to handle and avoid complications during interventions for structural heart disease, such as TAVI valve emboli, intra-aortic balloon occlusion, mitral leaflet tear, and more!
Cases in Japanese - PCI, MR & TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: PCI for coronary ischemia after EvolutR implantation, degenerative mitral regurgitation with large gap, bailout of ventricular septal defect after TAVI, and more!
MitraClip and challenging anatomies
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn from a selection of challenging Mitraclip cases, how to avoid and cope with various complications, such as single-leaflet device attachment and leaflet tear, mitral stenosis, chordal entanglement, and more!
Troubleshooting transcatheter aortic valve implantation (TAVI) for common complications: my worst nightmare - Part 2
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about how to provide practical troubleshooting on transcatheter aortic valve implantation (TAVI) for common complications, such as annulus rupture, aortic rupture and ischemic stroke, and get insight into the pre-procedural planning to prevent these complications.
Imaging Day - Case-based echo imaging for the aortic valve
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about low-flow low-gradient aortic stenosis, and discover how to predict prothesis-patient mismatch and how to detect prosthetic valve thrombosis.
Opening Ceremony - Tokyo Valves 2020
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 opening ceremony, learn more about PCR's mission, charter, companions, and discover what makes this course unique.
Abstracts from submissions - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to read 3 of the abstracts submitted for PCR Tokyo Valves 2020: thrombocytopenia after transfemoral TAVI, current generation transcatheter aortic valves in patients with large aortic annuli, and TAVI with Evolut R vs. Sapien 3 in small aortic annulus.
Closing Ceremony - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 closing ceremony, and discover who won the best clinical case and best abstract awards this year.
Coronary lithotripsy for stent underexpansion
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about coronary lithotripsy for stent underexpansion, and discover a selection of compelling cases: late stent thrombosis caused by severe stent underexpansion, delivering a stent through double layer of underexpanded stents implanted in heavily calcified plaque, and more!
Will the Evolut Low Risk trial change my practice?
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about the Evolut Low Risk TAVI trial, whose goal was to assess the safety and efficacy of transcatheter aortic valve replacement with the self-expanding CoreValve, compared with surgical aortic valve replacement in low-risk patients. Discover how its results apply to your practice!
Balloons that would not deflate: what works and what does not work!
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about balloons that would not deflate, and discover the innovative techniques used to face this challenge, thanks to various compelling cases.
Cardiovascular outcomes of SGLT-2 inhibitors and GLP-1 agonists in patients with diabetes and coronary artery disease
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about the cardiovascular outcomes of SGLT-2 inhibitors and GLP-1 agonists in patients with diabetes and coronary artery disease, and the clinical strategy for treatment implementation.
